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Abstract
Background
Current diagnostic methods for detection of Streptococcus pneumoniae in children with sus-
pected invasive pneumococcal disease have limitations of accuracy, timeliness, and patient
convenience. This study aimed to determine the performance of pneumococcal load quanti-
fied with a real-time polymerase-chain reaction in nasopharyngeal samples to diagnose
invasive pneumococcal disease in children.
Methods
Matched case-control study of patients <5 years of age with invasive pneumococcal disease
admitted to the Manhic¸a District Hospital (Mozambique) and asymptomatic controls
recruited in different periods between 2006 and 2014. Cases were confirmed by a positive
bacterial culture for S. pneumoniae in blood or cerebrospinal fluid. Nasopharyngeal aspi-
rates were collected from cases and controls and pneumococcal density was quantified by
lytA real-time polymerase-chain reaction.
Results
Thirty cases (median age 12.8 months) and sixty controls (median age 11.7 months) were
enrolled and 70% of them were male. Nasopharyngeal pneumococcal carriage was high in
both groups: 28/30 (93.3%) for cases vs. 53/60 (88.3%) for controls (p = 0.71). Mean
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nasopharyngeal pneumococcal load was identified as a marker for invasive pneumococcal
disease (7.0 log10 copies/mL in cases vs. 5.8 log10 copies/mL in controls, p<0.001) and
showed good discriminatory power (AUC-ROC: 82.1%, 95% CI 72.5%-91.8%). A coloniza-
tion density of 6.5 log10 copies/mL was determined as the optimal cut-off value to distinguish
cases from controls (sensitivity 75.0%, specificity 73.6%).
Conclusion
Use of non-invasive nasopharyngeal aspirates coupled with rapid and accurate quantifica-
tion of pneumococcal load by real-time polymerase chain reaction has the potential to
become a useful surrogate marker for early diagnosis of invasive pneumococcal disease in
children.
Introduction
The gram-positive bacterium Streptococcus pneumoniae (S. pneumoniae), a frequent colonizer
of the child’s nasopharynx, remains one of the major killers of children globally despite exten-
sive pneumococcal vaccination programs [1–3]. Occasionally, colonizing pneumococci spread
from their nasopharyngeal (NP) niche to normally sterile body sites and cause potentially life-
threatening invasive pneumococcal disease (IPD) [4]. The complex mechanisms underlying
the transition from NP colonization to IPD are far from being fully understood, although a
number of environmental, host, and pathogen-related risk factors have been identified [5–8].
Diagnosis of IPD remains challenging in children, as it requires collection of invasive sam-
ples and the use of sensitive methods to detect S. pneumoniae in small sample volumes [9]. Cul-
ture-based methods on sterile fluids are insensitive and time-consuming while rapid, simple,
non-invasive pneumococcal antigen detection tests on urine have become the mainstay for the
screening of pneumococcal infections in adults but show poor specificity in children [10]. Rel-
atively quick real-time polymerase-chain reaction (PCR) assays such as those targeting the lytA
gene accurately detect S. pneumoniae in small volumes of both invasive and non-invasive pedi-
atric samples [11], but are not easily accessible and feasible. In addition, since IPD and many
other common pediatric conditions share overlapping clinical presentation [12], empirical
diagnosis without microbiological confirmation can result in antibiotic misuse and increased
antimicrobial resistance in the community [13].
NP pneumococcal load, measured by real-time PCR or culture in non-invasive samples col-
lected from the upper respiratory tract, has been proposed as a candidate surrogate marker to
discriminate IPD from asymptomatic carriage, albeit with conflicting evidence [14–20]. In this
study, we aimed to determine whether pneumococcal load quantified with a lytA real-time
PCR in NP aspirates taken from a rural Mozambican pediatric population could be a marker
of IPD, while also taking into account other diverse pathogen- and host-related potential risk
factors.
Methods
Study design, site and population
This case-control study was conducted at the Manhic¸a District, Southern Mozambique,
between 2006 and 2014. The Centro de Investigação em Saúde de Manhiça (CISM) has been
running a Demographic Surveillance System (DSS) in the area since 1996 and a morbidity
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surveillance system at Manhic¸a District Hospital (MDH), covering an area at the time of the
study of around 500 km2, with ~92,000 people under permanent surveillance, 19% of which
less than 5 years of age [21]. The rural area of Manhic¸a is co-endemic for malaria, and severely
affected by the Human Immunodeficiency Virus (HIV) pandemic [22]. The ten-valent pneu-
mococcal conjugate vaccine was introduced in Mozambique in March 2013.
Selection of cases and controls. Data collection
Cases of IPD were prospectively selected among inpatients <5 years of age recruited as part of
invasive bacterial disease and pneumonia clinical studies at MDH [23,24] during the period
September 2006-May 2014, under a signed informed consent of their mothers or legal guard-
ians. Before the initiation of treatment, a NP aspirate was collected for both cases and controls
to determine pneumococcal load and respiratory viral infection. Venous blood was collected
for blood culture, full blood cell count, HIV and malaria testing.
Two asymptomatic controls for IPD of the same age (+/-3 months) and sex were randomly
selected in the community for each case from the DSS databases, and recruited during the
period September-November 2012, which span over both the hot rainy season and the dry
cooler season. A study clinician confirmed they were healthy prior to recruitment.
Variables recorded in cases and controls included patient age, sex, height, weight, weight-
for-age z (WAZ) score, nutritional status, recruitment season, co-infection with HIV or
malaria, NP carriage (lytA positivity), NP pneumococcal load among lytA positive samples,
pneumococcal serotype identification, serotype invasiveness potential, presence of other co-
colonizer pneumococci and respiratory viruses in the nasopharynx, and blood marker mea-
surements upon recruitment to the study. Children having received antibiotics in the previous
month were excluded from the study.
Definitions
IPD was defined as isolation of S. pneumoniae in blood or cerebrospinal fluid by culture.
Nutritional status was established according to weight-for-age z-scores [25] and children with
a weight-for-age z-score with a dispersion < -1SD were considered to be undernourished. The
hot rainy season was defined as November to April and the dry cooler season as May to Octo-
ber. Serogroups 1, 5 and serotype 7F/A were considered to have high invasive disease potential
as previously described [26].
Nasopharyngeal sample collection
A NP aspirate method was selected as the best procedure for reducing discomfort of infants
and young children during sampling. NP specimens were collected using NPAK1 kits
(M-Pro, Michigan, US). They were processed into aliquots (obtained by injecting a small 2–3
mL amount of physiological saline, and then aspirating) and immediately frozen at -80˚C. Fro-
zen samples were shipped to Hospital Sant Joan de De´u and Hospital Clinic, both in Barcelona
(Spain), where pneumococcal and respiratory virus studies were conducted, respectively.
Laboratory methods
Detection and quantification of S. pneumoniae. Samples and standard reference control
strains were extracted and concentrated by NucliSENS1 EasyMag1 (bioMe´rieux, Marcy
l’Etoile, France) from an initial sample volume of 400 μL to an elution volume of 110 μL. Five
micro liters of the DNA extract were added to the PCR reaction mix. A duplex real-time PCR
targeting the lytA gene of S. pneumoniae and the internal control targeting RNaseP of human
Nasopharyngeal pneumococcal load and IPD
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cells was performed. Sequence of primers and probes recommended by CDC for both the
pathogen and the internal control were used (http://www.cdc.gov/meningitis/lab-manual/
chpt10-pcr.html). DNA was amplified with the Applied Biosystems 7500 real-time PCR Sys-
tem (Applied Biosystems, CA, US).
Determination of PCR efficiency and the calibration curve for DNA quantification. A
calibration curve correlating DNA pneumococcal load with cycle threshold value was per-
formed by using reference strain S. pneumoniae R6. Given that genome-copy number is less
variable than colony forming unit (CFU) for establishing standards [27], loads were quantified
in genome-copy number which is about 2-logs higher than CFU. The calibration curve was
generated by extracting the genomic DNA from an original suspension of S. pneumoniae R6
strain (OD595 = 0.5) and performing 10-fold serial dilutions that ranged from 10
8 to 102 copies
per mL (cp/mL).
Pneumococcal serotyping. Capsular typing of pneumococci was directly performed in
lytA positive samples without culture by multiplex PCR combined with automated fluores-
cence capillary electrophoresis according to a previous method published by our group [28].
Other non-detectable serotypes by this technique were classified as indistinguishable serotypes
and were considered non-invasive for studying invasiveness potential. Patients with indistin-
guishable serotypes were excluded from the analysis of pneumococcal co-colonization as it
was not possible to assess the number of non-identified colonizing serotypes in those subjects
Detection of respiratory viruses. Detection of influenza A, B, C, respiratory syncytial
virus, adenovirus, coronavirus, enterovirus, human parainfluenza viruses 1, 2, 3, 4, human rhi-
novirus and human metapneumovirus was performed according to previously published stud-
ies [29,30].
Determination of HIV and malaria status. HIV-1 serodiagnosis was performed using a
sequential testing algorithm with two rapid HIV-1 antibody tests (Determine1 and Uni-
gold1). HIV-infection was confirmed when necessary by an HIV-1 DNA Amplicor test (ver-
sion 1.5, Roche Molecular Systems, Inc., Branchburg, NJ, US) while thick and thin blood films
were processed and examined according to standard methods for malaria diagnosis [31].
Statistical analysis
Dichotomous variables were examined with the Chi-square test or the Fisher’s exact test. Con-
tinuous variables were described as mean (standard deviation, SD) or median values (inter-
quartile range, IQR) and were compared using the t test for normal distributions or the Mann
Whitney test for skewed data. The variable of NP pneumococcal load (copies/mL) was log
transformed before inclusion in the analysis to assume a normal distribution. A preliminary
comparison of cases and controls was conducted to ensure that a number of factors of interest
were not differently distributed across groups. Logistic regression univariate and multivariate
analyses were performed to identify risk factors for IPD. Variables that were found to be signif-
icantly associated with IPD in the univariate analysis were entered into multivariate models.
The area under the receiver operating characteristic curve (AUC-ROC) was the parameter
used to select the most accurate predictive model and determine the optimal cut-off value of
NP pneumococcal load that maximizes sensitivity and specificity. Statistical significance was
set at a p-value of<0.05 and confidence intervals (CI) at 95% level. All analyses were per-
formed using Stata v.13 software (Stata Corp., College Station, TX, US).
Ethical approval
The different surveillance and biomarker studies from which cases and healthy controls were
drawn were approved in Mozambique by the Mozambican National Bioethics committee
Nasopharyngeal pneumococcal load and IPD
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(Refs: 98/CNBS/06; 262/CNBS/10 and 228/CNBS/12) and in Spain by the Ethics Committee of
the Hospital Clinic in Barcelona.
Results
Demographic characteristics of cases and controls
A total of 30 IPD patients and 60 healthy controls were included in the study. Males predomi-
nated in both groups (70%). The difference in median age between cases (12.8 months) and
controls (11.7 months) was minor (p = 0.37). Twenty-five cases (83.3%) and all controls were
recruited before the introduction of the pneumococcal conjugate vaccine in the country.
Recruitment was not influenced by seasonality: 16/30 (53.3%) cases were selected during the
dry cooler season vs. 26/60 (43.3%) controls (p = 0.37). Cases had a slightly lower body weight
than controls (8.1 kg vs. 8.8 kg, p = 0.06), and malnutrition, measured by WAZ scores was sig-
nificantly more prevalent in cases (70.0% vs. 41.7%, p = 0.01). Overall the two groups showed
comparable distributions of values for the potentially confounding factors of age, sex, and
recruitment season. Among cases, 23 presented bacteremic pneumococcal pneumonia, 2 had
pneumococcal meningitis and 5 had bacteremia without a clear focus. Demographic and epi-
demiological characteristics of the study participants are shown in Table 1.
Results of laboratory assays in cases and controls
NP pneumococcal carriage was highly prevalent in both groups: 28/30 (93.3%) in cases vs. 53/
60 (88.3%) in controls (p = 0.71). The calibration curve for NP pneumococcal DNA quantifica-
tion showed a linear behavior over six orders of magnitude, defining a linear range between
2.6•103 and 2.6•108 copies/mL. The correlation coefficient R2 was 0.997 and the slope of the
standard curve was -3.572 resulting in an efficiency of 90.6% for real-time PCR. Both parame-
ters fell within the acceptable limits previously established.
Among study samples, quantification of NP pneumococcal load by lytA real-time PCR
showed a significant difference in mean load between cases and controls (7.0 log10 copies/mL
vs. 5.8 log10 copies/mL, p<0.001). Capsular typing revealed that cases were more extensively
colonized by invasive serotypes 1, 5 and 7F/A (46.4% vs. 3.8%, p<0.001) and more frequently
co-colonized by different serotypes (84.0% vs. 39.0%, p<0.001). Considering all serotype car-
riage events separately in each group, the most frequent serotypes identified in cases were 7C/
(7B/40) (27.3%), 5 (10.6%), 6A/B (9.1%), and 23F (9.1%), whereas for controls, serotype 6A/B
predominated (19.7%), followed by 19F/C/B (14.8.%), 7C/(7B/40) (13.1%) and 14 (11.5%).
Table 1. Comparison of demographic and epidemiological characteristics in cases and controls.
Variable Case Group (n = 30) Control Group (n = 60) p value
Age, months, Md (IQR) 12.8 (9.8–25.0) 11.7 (8.5–19.9) 0.37
Age group, infants 12 (40.0) 32 (53.3) 0.23
Gender, male 21 (70.0) 42 (70.0) 1.00
Recruitment during dry season 16 (53.3) 26 (43.3) 0.37
Recruitment during the pre-vaccine era 25 (83.3) 60 (100.0) 0.003
Weight, kg, Md (IQR) 8.1 (6.1–10.0) 8.8 (8.0–11.1) 0.06
Underweight, WAZ< -1SD 21 (70.0) 25 (41.7) 0.01
Data expressed in No. (%), unless otherwise specified.
Abbreviations: WAZ, weight-for-age z-score; Md, median; IQR, interquartile range; SD, standard deviation.
https://doi.org/10.1371/journal.pone.0184762.t001
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Comparatively, mean NP pneumococcal load of cases recruited after the introduction of
the pneumococcal conjugate vaccine did not substantially differ from that of cases recruited in
the pre-vaccine period (6.8 log10 copies/mL vs. 7.1 log10 copies/mL, p = 0.52). Half of the cases
(50%) tested positive for HIV. HIV-positive cases did not present with a significantly higher
mean pneumococcal load than those being HIV-negative (7.3 log10 copies/mL vs. 6.8 log10
copies/mL, p = 0.22). Of note, data of co-infection with HIV were not available from control
samples. Malaria co-infection was detected in 2/30 (6.7%) of cases. Respiratory viral infection
(mono- or multiple) was highly prevalent in both cases (14/30, 46.7%) and controls (17/60,
28.3%), but the difference was not statistically significant (p = 0.08). A total of 33 viruses were
detected, 16 in cases and 17 in controls, with rhinovirus being the most predominant finding
in both groups (n = 25, in 10 cases and 15 controls), followed by adenovirus (n = 5, four cases
and one control), parainfluenza virus (n = 2, one case and one control), and influenza (n = 1,
one case).
Median hemoglobin (Hb) levels were significantly lower in cases than in controls (74 g/L
vs. 103 g/L, p<0.001), similarly to median hematocrit (HCT) values (23.5% vs. 31.0%,
p<0.001). In contrast, no significant differences were found in median platelet (PLT) and
white blood cell (WBC) counts. Table 2 describes results of laboratory microbiological and
hematological tests in the two groups.
Factors associated with IPD
NP pneumococcal load quantified by lytA real-time PCR, NP pneumococci co-colonization,
invasive serotypes, underweight, and Hb and HCT markers were significantly associated with
IPD in the univariate analysis. Particularly NP pneumococcal load showed good discrimina-
tory power between cases and controls (AUC-ROC: 82.1%, 95% CI 72.5%-91.8%). A coloniza-
tion density of 6.5 log10 copies/mL was determined to be the optimal cut-off value to
distinguish cases from controls, yielding sensitivity and specificity values of 75.0% and 73.6%,
respectively. A fair diagnostic accuracy was observed for serotype invasiveness (AUC-ROC:
71.3%, 95% CI 61.6%-81.8%), pneumococcal co-colonization (AUC-ROC: 72.5%, 95% CI
62.0%-83.0%), and underweight (AUC-ROC: 64.2%, 95% CI 53.7%-74.6%), while Hb and
HCT were poor predictors. Fig 1 depicts the ROC curves related to these risk factors
comparatively.
Variables significantly associated with IPD identified in the univariate analysis were consid-
ered for the multivariate analysis. However, given the high co-linearity found between Hb and
HCT (correlation coefficient r = 0.96, p<0.001) we decided to only include Hb in the modeling
process as a more meaningful potential marker for IPD than HCT. A model including NP
pneumococcal load, serotype invasiveness, and Hb proved to have the highest predictive
power (AUC-ROC: 98.2%, 95% CI 80.8%-94.0%) and high levels of sensitivity (92.6%) and
specificity (96.0%). The adjusted odds ratio for IPD per log unit increase of NP pneumococcal
load was 8.06 (95% CI 1.57–41.41, p = 0.01) in this model. Results of univariate and multivari-
ate analysis are presented in Table 3.
Discussion
This study provides robust evidence for the suitability of pneumococcal bacterial load mea-
sured with a lytA real-time PCR in NP aspirates as a proxy of IPD diagnosis in children. NP
pneumococcal load, once adjusted by a variety of potential host and pathogen risk factors, was
significantly higher among cases than in healthy controls. We were able to identify a threshold
value of 6.5 log10 copies/mL, which discriminated with moderately high sensitivity (75%) and
specificity (73.6%) between cases and controls.
Nasopharyngeal pneumococcal load and IPD
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The idea of such a discriminating threshold is not new, and has previously been explored
for diverse pneumococcal conditions, populations and sample types, but with unequal and
conflicting results. A study by Anh et al. documented high rates of colonization density (6
log10 CFU/mL) measured by culture among NP swab samples from Vietnamese children with
pneumonia [14]. A similarly high value of pneumococcal load (6 log10 copies/mL) quantified
by PCR in NP samples was reported by Vu et al. for children with community-acquired pneu-
monia with radiological confirmation in the same country [15] while Fan et al. observed a
slightly lower density (4.5–5 log10 copies/mL) for young Peruvian children with acute respira-
tory infection [16]. Interestingly, no threshold value for colonization density was established in
these pediatric studies, probably because of the difficulty to establish such a value among chil-
dren with disease and carriers, both of them having a high NP pneumococcal load.
In similar lines, Albrich et al. assessed the potential of quantitative lytA real-time PCR for
the diagnosis of pneumococcal pneumonia in NP swabs from South African adults [17], deter-
mining a threshold value of 8,000 copies/mL with a sensitivity of 82.2% and a specificity of
92.0%. In a subsequent study on the same population, they proposed a similar cut-off value of
10,000 copies/mL for good-quality sputum lytA real-time PCR, albeit with slightly lower
Table 2. Comparison of laboratory test results in cases and controls.
Variable Case Group (n = 30) Control Group (n = 60) p valuea,b
NP pneumococcal carriage 28/30 (93.3) 53/60 (88.3) 0.71a
NP lytA real-time PCR load, log10 cp/mL, mean (SD) 7.0 (0.9) 5.8 (1.0) <0.001
NP pneumococcus serotype high invasiveness potential 13/28 (46.4) 2/53 (3.8) <0.001
NP colonization with one serotype 4/28 (14.3) 25/53 (47.2) 0.003
NP co-colonization with 2 serotypes 8/28 (28.6) 12/53 (22.6) 0.56
NP co-colonization with 3 serotypes 6/28 (21.4) 4/53 (7.6) 0.09a
NP co-colonization with 4 serotypes 7/28 (25.0) 0/53 (0.0) <0.001a
NP colonization with non-identified serotypes 3/28 (10.7) 12/53 (22.6) 0.19
Serotypes carried, Md (IQR) 3 (2–4) 1 (1–2) <0.001b
PCV10 serotype coverage 25/28 (89.3) 31/53 (58.5) 0.004
PCV13 serotype coverage 25/28 (89.3) 38/53 (58.5) 0.07
HIV positive detection* 14/28 (50.0) - -
Malaria positive detection* 2/30 (6.7) 0/59 (0.0) 0.05a
Respiratory virus positive detection 14/30 (46.7) 17/60 (28.3) 0.08
Human rhinovirus 10/30 (33.3) 15/60 (25.0) 0.41
Adenovirus 4/30 (13.3) 1/60 (1.7) 0.02a
Influenza virus 1/30 (3.3) 0/60 (0.0) 0.16a
Parainfluenza virus 1/30 (3.3) 1/60 (1.7) 0.60a
Hb level, g/L, Md (IQR)* (cases: n = 29; controls: n = 57) 74 (66–99) 103 (94–110) <0.001b
HCT, Md (IQR)* (cases: n = 29; controls: n = 57) 23.5 (21.5–29.4) 31.0 (28.6–33.5) <0.001b
PLT, 103 cell/mm3, Md (IQR)* (cases: n = 29; controls: n = 57) 421 (342–536) 494 (388–563) 0.83a
WBC, 103 cell/mm3, Md (IQR)* (cases: n = 28; controls: n = 57) 14.4 (9.0–18.9) 12.8 (10.6–15.4) 0.17a
Data expressed as proportions (%), unless otherwise specified.
Abbreviations: NP, nasopharyngeal; Sp, Streptococcus pneumoniae; PCR, polymerase chain reaction; cp, copies; Md, median; IQR, interquartile range;
SD, standard deviation; PCV, pneumococcal conjugate vaccine; HIV, human immunodeficiency virus; Hb, hemoglobine; HCT, hematocrit; PLT, platelet;
WBC, white blood cell.
* Missing values
a Fisher’s exact test
b Mann-Whitney test
https://doi.org/10.1371/journal.pone.0184762.t002
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sensitivity and specificity values (78.1% and 80.0%, respectively), to discriminate HIV-infected
adults with pneumococcal pneumonia from controls [18]. Stralin et al. documented cut-off
values of 100 copies/mL for NP aspirates and 4.5 log10 copies/mL for sputum measured by
quantitative lytA real-time PCR in an elder Swedish pneumonia cohort [19]. Use of real-time
PCR detection on sputum samples was also postulated by Yang et al. for rapid diagnosis of
adult CAP pneumonia in an Emergency Department [20]. This group determined an AUC of
0.87 under the ROC curve, reporting sensitivity and specificity values of 90% and 80% respec-
tively for a cut-off of 37,000 copies/mL.
We speculate that the 2-log difference in the cut-off value between these studies on adult
populations and ours could primarily be due to the impaired immune response during first
years of life related with the high rates of carriage in children [32], in addition to different
Fig 1. Accuracy of diagnostic predictors for IPD. Abbreviations: NP, nasopharyngeal; Sp, Streptococcus
pneumoniae.
https://doi.org/10.1371/journal.pone.0184762.g001
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sampling and quantification methods and epidemiological characteristics. Given the high den-
sities of pneumococcal carriage (up to 8.5 log10 copies/mL) found in cases we estimate that the
relatively high threshold value calculated in our study (6.5 log10 copies/mL) may have diagnos-
tic utility to diagnose pediatric IPD.
A trend for a synergistic relationship in the univariate analysis between respiratory virus
co-infection and IPD was also identified but did not reach statistical significance. This out-
come is in disagreement with strong synergistic associations previously described between
pediatric pneumococcal pneumonia and viral co-infection [15] and between pediatric invasive
pneumococcal pneumonia and rhinovirus co-infection [33]. We hypothesize that the low
prevalence of influenza in our study population and the relatively stable incidence of rhinovi-
rus infection throughout the entire study period could explain that respiratory viral co-infec-
tion was not found to be a risk factor.
In recent years, technological advances have allowed integration of molecular diagnostics
into small footprint devices, which perform fast, simple, highly sensitive molecular assays at
the point of need. In the light of these diagnostic innovations, the potential implications and
applicability of our findings are promising, particularly for pediatric populations, who would
also benefit from the high diagnostic yield of NP washed in addition to the convenience of the
sampling method. As a novel biomarker, NP pneumococcal DNA load may allow designing
point-of-care tests capable of quantifying bacterial load in a simple manner. In addition, the
results of the multivariate analysis assessing independent risk factors for IPD suggest that the
adoption of a holistic approach by combining quantification of NP pneumococcal load with
serotype identification, and quantification of blood markers could substantially increase over-
all diagnostic yield. Such comprehensive approach would especially be suitable in reference
healthcare settings with laboratory infrastructures equipped to routinely perform all these
techniques.
This study has various important limitations. First, our total sample size was small, although
the analysis seems to have been sufficiently powered to show real differences in NP pneumo-
coccal load between cases and controls, and the differences observed between groups are bio-
logically plausible to prove the concept. Second, in spite of the fact that a case-control
approach appears suitable for the testing of the project’s hypothesis, restricting the selection of
controls to a short period of time once all cases had been recruited could have introduced
Table 3. Factors associated with IPD.
Variable Univariate analysis Multivariate analysis*
OR 95% CI p value Adjusted OR 95% CI p value
NP lytA real-time PCR load, per 1 log10 cp/mL increase 3.83 1.98–7.41 <0.001 8.06 1.57–41.41 0.01
NP pneumococcus invasive serotype vs. non invasive 22.10 4.48–109.04 <0.001 134.82 5.88–3093.30 0.002
NP pneumococcal co-colonization vs. single colonization 8.20 2.37–28.3 <0.001
Underweight vs. normal weight 3.27 1.28–8.32 0.01
Respiratory virus positive detection vs. negative 2.21 0.89–5.50 0.09
Hb level, per 1 g/L increase 0.92 0.88–0.95 <0.001 0.80 0.70–0.92 0.002
HCT, per 1% increase 0.75 0.66–0.86 <0.001
WBC, per 103 cell/mm3 increase 1.07 0.99–1.17 0.10
PLT, per 103 cell/mm3 increase 0.99 0.99–1.00 0.79
*Selected model
Abbreviations: OR, odds ratio; CI, confidence interval; NP, nasopharyngeal; PCR, polymerase chain reaction; cp, copies; Hb, hemoglobine; HCT,
hematocrite; PLT, platelet; WBC, white blood cell.
https://doi.org/10.1371/journal.pone.0184762.t003
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important biases in our results, particularly related to variability in patient’s characteristics, or
with year-to-year variations of the different infections (bacterial and viral) assessed, or the inci-
dence of infecting pneumococcal serotypes. A comparability analysis was performed to control
the potential confounding effect of seasonality on NP colonization density. However the small
sample size hinders our capacity to evaluate year-to-year variation of circulating serotypes.
Third, HIV status in controls was unknown but we have no reason to suspect that it could be
considerably different from that reported for healthy children in the same community, for
whom a low HIV prevalence in a range of 3–5% has been documented [12]. Moreover, when
we performed a sub-analysis of cases there were not significant differences in mean NP pneu-
mococcal load between HIV co-infected and not co-infected subjects, which suggests that this
factor does not substantially increase NP density of pneumococcus in young patients. Finally,
these results are drawn from a population with very high background prevalence rates of naso-
pharyngeal pneumococcal carriage, as previously described, and it remains to be seen whether
the threshold obtained in our study would remain valid in areas with lower carriage rates [34].
Conclusion
In conclusion, we propose a new diagnostic method which couples use of easily obtainable
non-invasive NP aspirates with rapid and accurate quantification of NP pneumococcal load by
lytA real-time PCR as a surrogate marker for IPD in children. Further validation is required to
confirm the clinical utility of this method.
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